Low risk of ipsilateral recurrence after distal ureterectomy for upper tract urothelial carcinoma

Authors

  • Fredrik Liedberg Department of Urology Skåne University Hospital, Malmö, and Institution of Translational Medicine, Lund University, Malmö, Sweden
  • Johannes Bobjer Department of Urology Skåne University Hospital, Malmö, and Institution of Translational Medicine, Lund University, Malmö, Sweden
  • Axel Gerdtsson Department of Urology Skåne University Hospital, Malmö, and Institution of Translational Medicine, Lund University, Malmö, Sweden
  • Petter Kollberg Department of Urology Skåne University Hospital, Malmö, and Institution of Translational Medicine, Lund University, Malmö, Sweden
  • Ioannis Patras Department of Urology Skåne University Hospital, Malmö, and Institution of Translational Medicine, Lund University, Malmö, Sweden
  • Anne Sörenby Department of Urology Skåne University Hospital, Malmö, and Institution of Translational Medicine, Lund University, Malmö, Sweden
  • Åsa Warnolf Department of Urology Skåne University Hospital, Malmö, and Institution of Translational Medicine, Lund University, Malmö, Sweden
  • Elin Ståhl Department of Urology Skåne University Hospital, Malmö, and Institution of Translational Medicine, Lund University, Malmö, Sweden https://orcid.org/0000-0002-3082-9704

DOI:

https://doi.org/10.2340/sju.v60.45014

Keywords:

upper urinary tract urothelial carcinoma, ureteral resection, kidney sparing surgery, ipsilateral recurrence

Abstract

N/A

Downloads

Download data is not yet available.

References

Liedberg F, Hagberg O, Aljabery F, et al. Diagnostic pathways and treatment strategies in upper tract urothelial carcinoma in Sweden between 2015 and 2021: a population-based survey. Scand J Urol. 2024;59:19–25. https://doi.org/10.2340/sju.v59.16281 DOI: https://doi.org/10.2340/sju.v59.16281

Masson-Lecomte A, Birtle AJ, Pradere B, et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: summary of the 2025 update. Eur Urol. 2025;87(6):697–716. https://doi.org/10.2340/sju.v59.16281 DOI: https://doi.org/10.1016/j.eururo.2025.02.023

Figaroa OJA, Hendriks N, Kamphuis GM, et al. Longer is better for endoscopic follow-up of upper tract urothelial carcinoma after ureteroscopic treatment: an evaluation spanning 10 years of data. Eur Urol Oncol. 2024;7(4):853–859. https://doi.org/10.1016/j.euo.2023.11.017 DOI: https://doi.org/10.1016/j.euo.2023.11.017

Masson-Lecomte A, Vaillant V, Roumiguie M, et al. Oncological outcomes of distal ureterectomy for high-risk urothelial carcinoma: a multicenter study by the French Bladder Cancer Committee. Cancers (Basel). 2022;14(21):5452. https://doi.org/10.3390/cancers14215452 DOI: https://doi.org/10.3390/cancers14215452

Dalpiaz O, Ehrlich G, Quehenberger F, et al. Distal ureterectomy is a safe surgical option in patients with urothelial carcinoma of the distal ureter. Urol Oncol. 2014;32(1):34 e1–8. https://doi.org/10.1016/j.urolonc.2013.01.001 DOI: https://doi.org/10.1016/j.urolonc.2013.01.001

Silberstein JL, Power NE, Savage C, et al. Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma. J Urol. 2012;187(2):429–34. https://doi.org/10.1016/j.uro.2011.09.150 DOI: https://doi.org/10.1016/j.juro.2011.09.150

Grasso M, Fishman AI, Cohen J, et al. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients. BJU Int. 2012;110(11):1618–26. https://doi.org/10.1111/j.1464-410X.2012.11066.x DOI: https://doi.org/10.1111/j.1464-410X.2012.11066.x

Cutress ML, Stewart GD, Tudor ECG, et al. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience. J Urol. 2013;189(6):2054–60. https://doi.org/10.1016/j.juro.2012.12.006 DOI: https://doi.org/10.1016/j.juro.2012.12.006

Kawada T, Laukhtina E, Quhal F, et al. Oncologic and safety outcomes for endoscopic surgery versus radical nephroureterectomy for upper tract urothelial carcinoma: an updated systematic review and meta-analysis. Eur Urol Focus. 2023;9(2):236–40. https://doi.org/10.1016/j.euf.2022.11.016 DOI: https://doi.org/10.1016/j.euf.2022.11.016

Karttunen E, Hervonen P, Hosseinin Aliabad A, et al. Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019. Scand J Urol. 2023;57(1–6):15–21. https://doi.org/10.1080/21681805.2022.2138965 DOI: https://doi.org/10.1080/21681805.2022.2138965

Downloads

Additional Files

Published

2025-12-10

How to Cite

Liedberg, F., Bobjer, J., Gerdtsson, A., Kollberg, P., Patras, I., Sörenby, A., … Ståhl, E. (2025). Low risk of ipsilateral recurrence after distal ureterectomy for upper tract urothelial carcinoma. Scandinavian Journal of Urology, 60, 209–212. https://doi.org/10.2340/sju.v60.45014

Issue

Vol. 60 (2025)

Section

Publications

License

Copyright (c) 2025 Fredrik Liedberg, Johannes Bobjer, Axel Gerdtsson, Petter Kollberg, Ioannis Patras, Anne Sörenby, Åsa Warnolf, Elin Ståhl

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

As from Volume 59 (2024) all published articles, unless otherwise specified, are published under CC-BY license, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, with the condition of proper attribution to the original work. 

Crossref
Scopus
Google Scholar
Europe PMC